These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3531034)

  • 1. A double-blind trial of fentonium bromide in the treatment of incontinent unstable bladder.
    Milani R; Merlo E; Scalambrino S; Viganò R
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):421-4. PubMed ID: 3531034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
    Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of effectiveness of and tolerance to oxybutynin in the treatment of unstable bladder in women].
    Serrano Brambila EA; Quiroga Avila RG; Lorenzo Monterrubio JL; Moreno Aranda J
    Ginecol Obstet Mex; 2000 Apr; 68():174-81. PubMed ID: 10824450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A; Wyndaele JJ; Sieber P
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of the symptoms of urinary urge and urge incontinence with propiverin hydrochloride (Mictonorm)].
    Blau U; Retzke U
    Zentralbl Gynakol; 1984; 106(14):981-7. PubMed ID: 6506904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double-blind trial of terodiline in the treatment of urge incontinence in women.
    Norton P; Karram M; Wall LL; Rosenzweig B; Benson JT; Fantl JA
    Obstet Gynecol; 1994 Sep; 84(3):386-91. PubMed ID: 8058236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine].
    Dorschner W; Stolzenburg JU; Griebenow R; Halaska M; Brünjes R; Frank M; Wieners F
    Aktuelle Urol; 2003 Mar; 34(2):102-8. PubMed ID: 14566693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effect of propiverine hydrochloride on urinary incontinence].
    Watanabe H; Uchida M; Kojima M
    Hinyokika Kiyo; 1998 Mar; 44(3):199-206. PubMed ID: 9589886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder.
    Rovner ES; Rackley R; Nitti VW; Wang JT; Guan Z;
    Urology; 2008 Sep; 72(3):488-93. PubMed ID: 18639327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence.
    Roehrborn CG; Abrams P; Rovner ES; Kaplan SA; Herschorn S; Guan Z
    BJU Int; 2006 May; 97(5):1003-6. PubMed ID: 16643482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder.
    Chapple C; Steers W; Norton P; Millard R; Kralidis G; Glavind K; Abrams P
    BJU Int; 2005 May; 95(7):993-1001. PubMed ID: 15839920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled double-blind trial on the clinical effects of the chenodeoxycholic acid-fentonium bromide combination in the symptomatic treatment of biliary spastic-dyskinetic conditions.
    Ricciardi S; Cerqua R
    Arzneimittelforschung; 1977; 27(6):1226-30. PubMed ID: 332188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effect of propiverine in patients with urge or stress incontinence. Kobe University Incontinence Study Group.
    Okada H; Sengoku J; Gohji K; Arakawa S; Kamidono S
    Hinyokika Kiyo; 1998 Jan; 44(1):65-9. PubMed ID: 9503214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
    Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
    J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of scopolamine in the treatment of detrusor instability.
    Muskat Y; Bukovsky I; Schneider D; Langer R
    J Urol; 1996 Dec; 156(6):1989-90. PubMed ID: 8911372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terodiline in the treatment of urinary frequency and motor urge incontinence. A controlled multicentre trial.
    Peters D
    Scand J Urol Nephrol Suppl; 1984; 87():21-33. PubMed ID: 6399953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of long-term safety and clinical benefit of terodiline in women with urgency/urge incontinence. A multicentre study.
    Fischer-Rasmussen W
    Scand J Urol Nephrol Suppl; 1984; 87():35-47. PubMed ID: 6443541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distigmine bromide and stress incontinence in women.
    Shah PJ; Abrams PH
    Prog Clin Biol Res; 1981; 78():329-34. PubMed ID: 6121333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder.
    Haab F; Stewart L; Dwyer P
    Eur Urol; 2004 Apr; 45(4):420-9; discussion 429. PubMed ID: 15041104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.